Clinical Trial RESULTS
Where can I learn more about the study?
If you have questions about the results, please speak with the doctor or staff at your study site. As of the spring
of 2017, you will be able to find more information about your study online at
www.clinicaltrials.gov/ct2/show/results/NCT02637037.
Official study title: A two part bioequivalence study to compare two fixed dose combination (FDC) tablets
of dapagliflozin/metformin XR 5/500 mg (Part 1) and 10/1000 mg (Part 2) manufactured at two different plants
(Humacao, Puerto Rico and Mount Vernon, United States [US]) in healthy subjects under fasting and
fed conditions
AstraZeneca AB, the sponsor of this study, is a member of the AstraZeneca Group of companies and has
its headquarters at 1800 Concord Pike, PO Box 15437, Wilmington, DE 19850 USA.
The phone number for the AstraZeneca Information Center is 1-877-240-9479.
The results presented here are for a single study. Other studies may provide new information or different
results. You should not make changes to your therapy based on the results of a single study without first
consulting your healthcare professional.
Thank you
It is said that the greatest gift is one which is
given anonymously, giving when you do not know
whether you will get direct personal benefit.
This is the gift that you have given by taking part in a
clinical trial. It is a brave and selfless act, one that advances
medical knowledge and benefits public health.
Thank you for the gift of your participation in this clinical research.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization
focused on educating and informing the public about
clinical research participation. CISCRP is not involved in
recruiting participants for clinical trials, nor is it involved
in conducting clinical trials.
CISCRP
56 Commercial Wharf East
Boston, MA 02110
1-877-MED-HERO
www.ciscrp.org
8
Trial Results Summary v1 10/2016